The case of 2024 New Quality Productivity Empowering High Quality Development was released. On December 10th, 2024 China Brand Forum New Quality Productivity Empowering High Quality Development Forum was held in Zhengzhou. At the meeting, the case of high-quality development of new quality productivity in 2024 was released, and 20 enterprises including China Railway Equipment, BYD, Yutong Group, Chihiro Location and Ubisoft Technology were selected. (Dahe Finance Cube)World Bank: Kenya's growth forecast for 2024 is lowered to 4.7% due to financial challenges.Reserve Bank of Australia President Brock: The upward inflation risk under discussion has eased, but it has not disappeared. We need to see more progress in basic inflation.
Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.Morgan Stanley published a research report that Jingdong Logistics management predicted that the net profit growth in FY 2024 would increase by 49% year-on-year, far exceeding the bank's expected 30% increase. As for the profit growth forecast for next year, it is 9% year-on-year. The bank also believes that the acquisition of Jingdong Logistics across the remaining rights and interests of Express is positive and is expected to have further synergy. Morgan Stanley set the target price of H shares of Jingdong Logistics at HK$ 13.1, giving it a rating of "keeping pace with the market"."Nature" announced the top ten figures in 2024, and two China scientists were selected. On the 9th, the website of the British magazine "Nature" released the list of the top ten figures promoting scientific development in 2024. Among them, two China scientists were selected. The list was compiled by the editors of Nature magazine to record the important scientific progress, events and some key figures this year. Among them, two China researchers who were selected as the top ten were Xu Huji, a rheumatologist from the PLA Naval Medical University, and Li Chunlai, deputy chief designer of the Chang 'e VI mission and a researcher at the National Astronomical Observatory of the Chinese Academy of Sciences. Dr. Xu Huji bravely tried to treat autoimmune diseases with CAR-T cell therapy, which brought hope for the mass production of CAR-T cell therapy. Li Chunlai was a key figure in determining the landing site of Chang 'e-6 probe on the moon, and was also one of the first scientists to analyze the returned samples.
Hongya CNC: The income from exporting products to the US market is relatively low. Hongya CNC (002833) said on the interactive platform today that the company's products are exported to more than 70 countries and regions, and the income from the US market is relatively low.Australian Treasury Secretary chalmers: The new A $2 billion expenditure on natural disaster preparedness will affect the mid-year economic and financial outlook.World Bank: Kenya's growth forecast for 2024 is lowered to 4.7% due to financial challenges.
Strategy guide 12-13
Strategy guide
12-13